SGK adds 47 drugs to reimbursement list
The Social Security Institution (SGK) has added 47 more drugs to its list of reimbursed medications, including 8 innovative cancer drugs. It was stated that 8 of the drugs are innovative cancer medications, also known as "smart drugs," and 10 are domestically produced.
The "Communiqué on Amendments to the Social Security Institution Health Implementation Communiqué" has been published in the Official Gazette.
Accordingly, 47 more drugs have been added to the list of medications covered by the SGK, including 8 innovative cancer drugs also known as "smart drugs," 21 allergy vaccines, 2 growth hormones, 3 resistant scabies medications, 3 atopic dermatitis medications, 2 diabetes medications, and 3 psycholeptics/antidepressants.
Additionally, the reimbursement scope for 12 cancer drugs has been expanded, making them available to patients as new treatment options.
It was noted that 10 of the drugs are domestically produced.
With this change, it was reported that citizens have been provided access to innovative drugs used in the treatment of breast cancer, bladder cancer, prostate cancer, lung cancer, Resistant Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Multiple Myeloma (MM).
News Source: AA
Most Read
Historic words from Özgür Özel at the CHP group meeting
Air Force Academy student Veli Bilgin has died
Tuncer Bakırhan calls for a framework law
Here are the names that will be in Özgür Özel's new party!
How did the newspapers view Özgür Özel's farewell to the CHP?
Major crisis in CHP
He killed his wife by slitting her throat: Their children witnessed the moments
AKP mayor held responsible
Kılıçdaroğlu's 'controlled' shopkeeper visit
Güler leaves questions regarding Özgür Özel unanswered